Learning points
▸ In patients with known non-Hodgkins lymphoma (NHL) and pulmonary infiltrates, lung biopsy yields specific diagnoses in only 50% of cases. 1 Secondary involvement of the lung in patients with lymphoma has an incidence of 25-40%. 2 A disappointing reminder of the limitations of lung biopsy as an aid to definite diagnosis for pathology involving the lung parenchyma. ▸ This patient had symptoms and signs of interstitial lung disease. There were no palpable lymph nodes and no significant mediastinal lyphadenopathy on CT to indicate lymph node biopsy for diagnosis by mediastinoscopy. Unfortunately, this patient had no other symptoms or signs to suggest pathology elsewhere, until seizures led to an MRI showing lesions in the brain. Tumour markers remained negative. ▸ An atypical presentation of fevers and mass effect ( pneumonitis in this case) without other typical symptoms of fatigue, weight loss or night sweats should elicit a high degree of suspicion for lymphoma and appropriate whole body scanning initiated to aid in diagnosis. Even with inconclusive results from lung biopsy, other sources of tissue diagnosis must be sought. Delays in definitive diagnosis can lead to an unfortunate outcome. 
